Andreas Jönsen
81 – 90 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
-
Mark
Variations in the epidemiology of systemic lupus erythematosus in southern Sweden.
2016) In Lupus(
- Contribution to journal › Article
-
Mark
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
(
- Contribution to journal › Article
-
Mark
Case definitions in Swedish register data to identify systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.
(
- Contribution to journal › Article
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.
(
- Contribution to journal › Article
-
Mark
Systemic Lupus Erythematosus Prevalence in Sweden in 2010: What Do National Registers Say?
(
- Contribution to journal › Article
- 2013
-
Mark
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article